Expression of beta-galactosidase gene and endothelial nitric oxide synthase gene in rat vascular smooth muscle cells after in vitro lipotransfection.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Clinica chimica acta; international journal of clinical chemistry

• Publication date

  1999-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0009-8981(99)00049-2PMID 10529453
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety and Short-term Toxicity of a Novel Cationic Lipid Formulation for Human Gene Therapy

  2009cited by this paper
• Angiogenesis for revascularization of ischaemic tissues.

  1997cited by this paper
• Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.

  1997cited by this paper
• Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening.

  1997cited by this paper
• Native and Modified Low Density Lipoproteins Increase the Functional Expression of the Macrophage Class B Scavenger Receptor, CD36*

  1997cited by this paper
• Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA

  1997cited by this paper
• Prostacyclin and nitric oxide-related gene transfer in preventing arterial thrombosis and restenosis.

  1997cited by this paper
• Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration

  1997cited by this paper
• Macrophage depletion increases the safety, efficacy and persistence of adenovirus-mediated gene transfer in vivo

  1997cited by this paper
• High efficiency reporter gene transfection of vascular tissue in vitro and in vivo using a cationic lipid–DNA complex

  1997cited by this paper
• Safety studies of the intraperitoneal injection of E1A–liposome complex in mice

  1997cited by this paper
• Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis

  1997cited by this paper
• Gene therapy for arterial thrombosis.

  1997cited by this paper
• Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery.

  1997cited by this paper
• In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes

  1997cited by this paper
• Prostacyclin and nitric oxide-related gene transfer in preventing arterial thrombosis and restenosis.

  1997cited by this paper
• Gene therapy with angiogenic factors: a new potential approach to the treatment of ischemic diseases.

  1997cited by this paper
• Characterization of Cationic Liposome-Mediated Gene Transfer In Vivo by Intravenous Administration

  1997cited by this paper
• A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis

  1997cited by this paper
• Anti‐inflammatory activity of cationic lipids

  1997cited by this paper
• Importance of liposome complexing volume in transfection optimization.

  1996cited by this paper
• Vascular inducible nitric oxide synthase gene therapy: requirement for guanosine triphosphate cyclohydrolase I.

  1996cited by this paper
• Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer.

  1996cited by this paper
• Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer.

  1996cited by this paper
• Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes.

  1996cited by this paper
• Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion.

  1996cited by this paper
• Adenoviral gene transfer of nitric oxide synthase: high level expression in human vascular cells.

  1996cited by this paper
• Impairment of Force Generation after Adenovirus-Mediated Gene Transfer to Muscle Is Alleviated by Adenoviral Gene Inactivation and Host CD8+ T Cell Deficiency

  1996cited by this paper
• Vascular Gene Transfer of the Human Inducible Nitric Oxide Synthase: Characterization of Activity and Effects on Myointimal Hyperplasia

  1996cited by this paper
• Correction of hypertension by normalization of endothelial levels of fibroblast growth factor and nitric oxide synthase in spontaneously hypertensive rats.

  1996cited by this paper
• Molecular Therapies for Vascular Diseases

  1996cited by this paper
• Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia.

  1996cited by this paper
• Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

  1995cited by this paper
• Cationic Liposome-mediated Intravenous Gene Delivery (*)

  1995cited by this paper
• Fusion of cationic liposomes with mammalian cells occurs after endocytosis.

  1995cited by this paper
• Gene therapy inhibiting neointimal vascular lesion

  1995cited by this paper
• Gene therapy for the vulnerable plaque.

  1995cited by this paper
• Liposome-mediated gene transfer into human vascular smooth muscle cells.

  1994cited by this paper
• New structures in complex formation between DNA and cationic liposomes visualized by freeze—fracture electron microscopy

  1994cited by this paper
• Complex models for the study of gene function in cardiovascular biology.

  1994cited by this paper
• Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy.

  1993cited by this paper
• A fluorometric assay for the measurement of nitrite in biological samples.

  1993cited by this paper
• Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice.

  1992cited by this paper
• Gene Transfer In Vivo with DNA–Liposome Complexes: Safety and Acute Toxicity in Mice

  1992cited by this paper
• A novel cationic liposome reagent for efficient transfection of mammalian cells.

  1991cited by this paper
• Cationic liposome-mediated transfection

  1989cited by this paper
• Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Liposome-mediated DNA transfer in eukaryotic cells. Dependence of the transfer efficiency upon the type of liposomes used and the host cell cycle stage.

  1982cited by this paper

• Efficient Transfection Method for Primary Cells

  2002cites this paper
• In vitro and in vivo study of the expression vector encoding vascular endothelial growth factor.

  2001cites this paper
• Vascular endothelial growth factor synthesis in vascular smooth muscle cells is enhanced by 7-ketocholesterol and lysophosphatidylcholine independently of their effect on nitric oxide generation.

  2001cites this paper
• Vascular endothelial growth factor is efficiently synthesized in spite of low transfection efficiency of pSG5VEGF plasmids in vascular smooth muscle cells

  2000cites this paper